Sanguine is a company that has the mission to accelerate medical research by eliminating the barriers to patient participation. In the process, the company elevates the role of the patient in the research effort, ensuring that the purpose of better patient outcomes is at the center of every study.
The company delivers advanced scientific breakthroughs to patients from the comfort of their home. Its patient-centered approach to biospecimen collection makes it easy for patients to participate in medical research and have a direct impact on the development of new treatments.
The company allows researchers to have access to “impossible” samples with its patient-centric approach to biospecimen collection. Through communications, patient support, and compensation, Sanguine keeps patients engaged in the research process for a better patient experience and more impactful research biospecimens.